论文部分内容阅读
我院自1954年到1989年底共手术治疗50例男性乳腺癌，占同期经治可手术全部乳腺癌7050例的0.71％。其中Ⅰ期8例，Ⅱ期21例，Ⅲ期20例及原发双侧者1例（右侧Ⅱ期，左侧Ⅲ期）。行扩大根治手术者6例，传统根治手术者31例，改良根治术者6例，全乳切除者5例（原发双侧者两侧均行全乳切除术，按1例计算）及局部切除术者2例。本组病例的5年生存率为78．7％，10年生存率为31．6％。本研究同时对男性乳腺癌的发病及预后因素进行了探讨。
In our hospital from the end of 1954 to the end of 1989, 50 male breast cancers were treated surgically, accounting for 0.71% of 7050 breast cancers that could be treated in the same period. Among them, 8 cases were in stage I, 21 cases in stage II, 20 cases in stage III, and 1 case in primary bilateral (right stage II, left stage III). Six patients underwent extended radical surgery, 31 patients underwent conventional radical surgery, 6 patients underwent modified radical mastectomy, and 5 patients underwent mastectomy (primary bilateral patients underwent total mastectomy on both sides, calculated in 1 case) and local The resection was performed in 2 patients. The 5-year survival rate for this group was 78.7%, and the 10-year survival rate was 31.6%. This study also investigated the onset and prognostic factors of male breast cancer.